Insider

IFF announces new heart‑health claim for soy protein in Australia and New Zealand

IFF said the new heart‑health claim for isolated soy protein is available in Australia and New Zealand, setting a daily intake of 20–25 g; SUPRO® Soy Proteins can help achieve this range.

Verified against 1 archived primary source · SHA-256 recorded Inspect sources & citations ↓
a jar of protein powder next to a scoop of powder
Photo by Alex Saks on Unsplash
20–25 g
Daily protein target

Key points

  • On 21 September 2026, IFF reported that the heart‑health claim for isolated soy protein is permitted in Australia and New Zealand.
  • Scientific data confirming soy protein’s role in supporting heart health allow brands in ANZ to include the claim in their products.
  • The claim’s availability does not guarantee market uptake.

New heart‑health claim in ANZ

On 21 September 2026, IFF reported that the heart‑health claim for isolated soy protein is permitted in Australia and New Zealand. It defines a daily intake of 20–25 g, and SUPRO® Soy Proteins can help brands meet this range.

Why it matters

Scientific data confirming soy protein’s role in supporting heart health allow brands in ANZ to include the claim in their products. The defined daily range of 20–25 g gives developers a clear target, and SUPRO® Soy Proteins provide the technology to reach this level in formulated foods.

Risks and unknowns

The claim’s availability does not guarantee market uptake. Brands may choose not to use it, or select other suppliers, and demand for soy protein could remain weak.

What to watch

Investors should monitor news of ANZ brands adopting the heart‑health claim and any disclosures of SUPRO® Soy Proteins sales volumes.

Original sources

  1. A heart health claim just opened a new growth lane in ANZ. Here’s how to move first.September 21, 2026SHA-256 of our archived copy dc844c64858b…
Cite this article

The fingerprint identifies the exact version of each original that the article was written from; the original stays at its source.

Prepared by AI from official company documents; automatic checks and an AI editor review it before publication, and not every article is read by a person. This is not investment advice. Editorial standards